Aquatic Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-4,200
Closed -$282K – 1468
2023
Q4
$282K Sell
4,200
-500
-11% -$34.8K 0.01% 765
2023
Q3
$352K Buy
+4,700
New +$417K 0.01% 552
2023
Q2
– Sell
-5,900
Closed -$612K – 1596
2023
Q1
$612K Buy
+5,900
New +$654K 0.04% 374
2022
Q4
– Sell
-3,400
Closed -$368K – 1633
2022
Q3
$368K Buy
3,400
+3,100
+1,033% +$444K 0.04% 478
2022
Q2
$54K Buy
300
+200
+200% +$35.8K 0.02% 630
2022
Q1
$17K Sell
100
-100
-50% -$18.9K 0.03% 534
2021
Q4
$42K Buy
+200
New +$41.3K 0.08% 358

Other funds holding MED

Aquatic Capital Management's MED Position: Q1 2024 in Review

Aquatic Capital Management sold out of Medifast (MED) in Q1 2024, closing a stake of 4,200 shares — an estimated $282K sold.

Aquatic Capital Management first reported a position in MED in Q4 2021 and held it in 7 quarters. The position peaked at $612K in Q1 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Aquatic Capital Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 4,200 Medifast shares in Q1 2024, an estimated $282K.
  • Aquatic Capital Management first reported a position in Medifast in Q4 2021 and held it in 7 quarters.
  • Aquatic Capital Management's Medifast position peaked at $612K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Aquatic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.